By
definition, Class I antiarrhythmic's
primary mechanism of action is Na+ channel blockade. Some also block the K+ channel significantly (i.e. Class Ia), while other do to a much lesser extent, if at all (i.e. Class Ic).
Here's a link to an article where someone felt that it was rare enough to get torsades with flecainide, that it warranted a case report:
http://onlinelibrary.wiley.com/doi/10.1002/phar.1403/abstract
Also, see here:
http://emedicine.medscape.com/article/2172024-overview?pa=LdlepnQBnb9AIg6HQDBS3zmjLwleUtR6PHr/CdtsVfdmZehiWt2C02zj+ypef3Ni3V2zxLFOu9AF/HZt4/lJoichrzF/7vlnSF6AEX/09M8=
"Ia -
Quinidine,
procainamide,
disopyramide (depress phase 0, prolonging repolarization)
Ib -
Lidocaine,
phenytoin,
mexiletine (depress phase 0 selectively in abnormal/ischemic tissue, shorten repolarization)
Ic -
Flecainide,
propafenone, moricizine (markedly depress phase 0,
minimal effect on repolarization"
In summary, flecainide likely has minimal blockade on K+ channels that in rare cases can cause prolonged QT. For Step I purposes (and as per First Aid), only classes Ia and III have significant K+ channel blockade, and therefore can prolong QT.